BR112021013772A8 - Água eletrolisada, método para obter a mesma e usos de tal água para tratar distúrbios relacionados à senescência da célula - Google Patents

Água eletrolisada, método para obter a mesma e usos de tal água para tratar distúrbios relacionados à senescência da célula

Info

Publication number
BR112021013772A8
BR112021013772A8 BR112021013772A BR112021013772A BR112021013772A8 BR 112021013772 A8 BR112021013772 A8 BR 112021013772A8 BR 112021013772 A BR112021013772 A BR 112021013772A BR 112021013772 A BR112021013772 A BR 112021013772A BR 112021013772 A8 BR112021013772 A8 BR 112021013772A8
Authority
BR
Brazil
Prior art keywords
water
disorders related
cell senescence
same
treat disorders
Prior art date
Application number
BR112021013772A
Other languages
English (en)
Other versions
BR112021013772A2 (pt
Inventor
Pupunat Laurent
Ginter Anthony
Original Assignee
Waterdiam Group Llc
Weo LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Waterdiam Group Llc, Weo LLC filed Critical Waterdiam Group Llc
Publication of BR112021013772A2 publication Critical patent/BR112021013772A2/pt
Publication of BR112021013772A8 publication Critical patent/BR112021013772A8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F1/00—Treatment of water, waste water, or sewage
    • C02F1/46—Treatment of water, waste water, or sewage by electrochemical methods
    • C02F1/461—Treatment of water, waste water, or sewage by electrochemical methods by electrolysis
    • C02F1/46104—Devices therefor; Their operating or servicing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/10—Bag-type containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A61K35/08—Mineral waters; Sea water
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20—Halogens; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F1/00—Treatment of water, waste water, or sewage
    • C02F1/46—Treatment of water, waste water, or sewage by electrochemical methods
    • C02F1/461—Treatment of water, waste water, or sewage by electrochemical methods by electrolysis
    • C02F1/46104—Devices therefor; Their operating or servicing
    • C02F1/46109—Electrodes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/83—Electrophoresis; Electrodes; Electrolytic phenomena
    • C—CHEMISTRY; METALLURGY
    • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F1/00—Treatment of water, waste water, or sewage
    • C02F1/46—Treatment of water, waste water, or sewage by electrochemical methods
    • C02F1/461—Treatment of water, waste water, or sewage by electrochemical methods by electrolysis
    • C02F1/46104—Devices therefor; Their operating or servicing
    • C02F1/46109—Electrodes
    • C02F2001/46133—Electrodes characterised by the material
    • C02F2001/46138—Electrodes comprising a substrate and a coating
    • C02F2001/46142—Catalytic coating
    • C—CHEMISTRY; METALLURGY
    • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F1/00—Treatment of water, waste water, or sewage
    • C02F1/46—Treatment of water, waste water, or sewage by electrochemical methods
    • C02F1/461—Treatment of water, waste water, or sewage by electrochemical methods by electrolysis
    • C02F1/46104—Devices therefor; Their operating or servicing
    • C02F1/46109—Electrodes
    • C02F2001/46133—Electrodes characterised by the material
    • C02F2001/46138—Electrodes comprising a substrate and a coating
    • C02F2001/46147—Diamond coating
    • C—CHEMISTRY; METALLURGY
    • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F2103/00—Nature of the water, waste water, sewage or sludge to be treated
    • C02F2103/02—Non-contaminated water, e.g. for industrial water supply
    • C02F2103/026—Treating water for medical or cosmetic purposes
    • C—CHEMISTRY; METALLURGY
    • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F2201/00—Apparatus for treatment of water, waste water or sewage
    • C02F2201/46—Apparatus for electrochemical processes
    • C02F2201/461—Electrolysis apparatus
    • C02F2201/46105—Details relating to the electrolytic devices
    • C02F2201/4612—Controlling or monitoring
    • C02F2201/46125—Electrical variables
    • C—CHEMISTRY; METALLURGY
    • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F2201/00—Apparatus for treatment of water, waste water or sewage
    • C02F2201/46—Apparatus for electrochemical processes
    • C02F2201/461—Electrolysis apparatus
    • C02F2201/46105—Details relating to the electrolytic devices
    • C02F2201/4612—Controlling or monitoring
    • C02F2201/46125—Electrical variables
    • C02F2201/4614—Current
    • C—CHEMISTRY; METALLURGY
    • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F2201/00—Apparatus for treatment of water, waste water or sewage
    • C02F2201/46—Apparatus for electrochemical processes
    • C02F2201/461—Electrolysis apparatus
    • C02F2201/46105—Details relating to the electrolytic devices
    • C02F2201/4612—Controlling or monitoring
    • C02F2201/4615—Time

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Birds (AREA)
  • Biotechnology (AREA)
  • Electrochemistry (AREA)
  • Hydrology & Water Resources (AREA)
  • Environmental & Geological Engineering (AREA)
  • Water Supply & Treatment (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

ÁGUA ELETROLISADA, MÉTODO PARA OBTER A MESMA E USOS DE TAL ÁGUA PARA TRATAR DISTÚRBIOS RELACIONADOS À SENESCÊNCIA DA CÉLULA. A presente invenção refere-se a um método para obter água eletrolisada, sendo que o método compreende as seguintes etapas: - adicionar sal condutor a uma concentração de 0,5 a 2 g/l na água não tratada - eletrolisar a água obtida em i) usando-se um módulo de eletrólise que compreende pelo menos um eletrodo de diamante dopado com boro fixado em um substrato de silício no qual a concentração de boro está entre 200 ppm (3x1019 B átomos/cm3) e 1500 ppm (2x1020 B átomos/cm3), sendo que a duração de eletrólise fica entre 1 e 30 minutos. A invenção também se refere a uma água obtida de acordo com o dito método para tratar doenças ou distúrbios relacionados à senescência da célula e a uma composição que contém tal água, a um método para aumentar o caráter senolítico de células senescentes e a um dispositivo para tratar afecções de pele, que compreende um reservatório ou bolsa de infusão que contém uma água obtida de acordo com o método da invenção.
BR112021013772A 2019-01-20 2020-01-17 Água eletrolisada, método para obter a mesma e usos de tal água para tratar distúrbios relacionados à senescência da célula BR112021013772A8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1900482A FR3091864B1 (fr) 2019-01-20 2019-01-20 Eau électrolysée, procédé d’obtention et utilisations d’une telle eau pour le traitement de désordres liés à la sénescence cellulaire
FR1900482 2019-01-20
PCT/EP2020/051200 WO2020148453A1 (fr) 2019-01-20 2020-01-17 Eau électrolysée, procédé d'obtention et utilisations d'une telle eau pour le traitement de désordres liés à la sénescence cellulaire

Publications (2)

Publication Number Publication Date
BR112021013772A2 BR112021013772A2 (pt) 2021-09-21
BR112021013772A8 true BR112021013772A8 (pt) 2023-01-31

Family

ID=69104461

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112021013772A BR112021013772A8 (pt) 2019-01-20 2020-01-17 Água eletrolisada, método para obter a mesma e usos de tal água para tratar distúrbios relacionados à senescência da célula

Country Status (10)

Country Link
US (1) US20220079977A1 (pt)
EP (1) EP3911608A1 (pt)
JP (1) JP2022518218A (pt)
CN (1) CN113365951A (pt)
AU (1) AU2020208932A1 (pt)
BR (1) BR112021013772A8 (pt)
EA (1) EA202191697A1 (pt)
FR (1) FR3091864B1 (pt)
IL (1) IL284828A (pt)
WO (1) WO2020148453A1 (pt)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5503287B2 (ja) * 2006-09-05 2014-05-28 エレメント シックス リミテッド 固体電極
WO2010148447A1 (en) * 2009-06-23 2010-12-29 Centenary Institute Of Cancer Medicine And Cell Biology A novel regulator of cellular senescence
KR20120051929A (ko) * 2010-11-15 2012-05-23 가톨릭대학교 산학협력단 산화적 스트레스로 인한 뇌신경세포 사멸을 억제하는 뇌신경계 질환 예방 또는 치료용 검정콩 안토시아닌을 포함하는 조성물
CH706747A2 (de) * 2012-07-17 2014-01-31 Hanspeter Steffen Verfahren zur Hydration, Straffung und Pflege der Haut, zur Behandlung von Dermatosen, Sonnenbrand und genereller Wunden mit Diamantelektroden hergestelltem Elektrolysewasser.
CH706750A2 (de) * 2012-07-19 2014-01-31 Hanspeter Steffen Verfahren zur intravenösen Injektion von isotonisch-physiologischem Elektrolysewasser zur Bekämpfung von systematischen Virosen und Bakteriosen mittels oxidativen Radikalen.
AU2015211021B2 (en) 2014-01-28 2020-07-02 Buck Institute For Research On Aging Methods and compositions for killing senescent cells and for treating senescence-associated diseases and disorders
GB201708456D0 (en) 2017-05-26 2017-07-12 Medical Res Council Senolytic compounds

Also Published As

Publication number Publication date
US20220079977A1 (en) 2022-03-17
FR3091864A1 (fr) 2020-07-24
AU2020208932A1 (en) 2021-08-05
WO2020148453A1 (fr) 2020-07-23
EA202191697A1 (ru) 2021-10-25
FR3091864B1 (fr) 2022-07-29
EP3911608A1 (fr) 2021-11-24
CN113365951A (zh) 2021-09-07
BR112021013772A2 (pt) 2021-09-21
JP2022518218A (ja) 2022-03-14
IL284828A (en) 2021-08-31

Similar Documents

Publication Publication Date Title
Raiteri et al. Presynaptic muscarinic receptors increase striatal dopamine release evoked by ‘quasi-physiological’depolarization
Zisapel et al. Inhibition by melatonin of dopamine release from rat hypothalamus: regulation of calcium entry
BR112021013772A8 (pt) Água eletrolisada, método para obter a mesma e usos de tal água para tratar distúrbios relacionados à senescência da célula
RU2010140351A (ru) Композиции, включающие ингибитор nfкв и неретиноидный стимулятор образования коллагена
BR112021009675A8 (pt) Água, método de obtenção de água eletrolisada, composição que compreende a dita água e dispositivo para o tratamento de doenças inflamatórias cutâneas
Benedusi et al. Circadian clock as possible protective mechanism to pollution induced keratinocytes damage
Pan et al. Preserving GABAergic interneurons in acute brain slices of mice using the N-methyl-D-glucamine-based artificial cerebrospinal fluid method
BR112024000731A2 (pt) População de células exterminadoras naturais de memória purificadas, células nk de memória, método para produzir células nk de memória, e, método para tratar uma malignidade proliferativa
Eva et al. Changes of cholinergic, noradrenergic and serotonergic synaptic transmission indices elicited by ethylcholine aziridinium ion (AF64A) infused intraventricularly.
Allaway et al. Stomatal responses to changes in carbon dioxide concentration in leaves treated with 3‐(4‐chlorophenyl)‐1, 1‐dimethylurea
Su Modes of vasoconstrictor and vasodilator neurotransmission
MA35442B1 (fr) Remineralisation d'eau desalinisee et d'eau douce par dosage d'une de solution de carbonate de calcium dans de l'eau adoucie
Letarte et al. Glucose metabolism in fat cells stimulated by insulin and dependent on sodium
Richter et al. Hyperpolarization-activated cation currents in stellate and pyramidal neurons of rat entorhinal cortex
Shanes Potassium retention in crab nerve
Cichini et al. Effects of clonidine on the stimulation-evoked release of 3 H-noradrenaline from superfused rat brain slices as a function of the biophase concentration: Temperature dependent widening of extracellular space
Suarez-Kurtz et al. Effect of local anesthetics on radiocalcium binding in nerve
Hörtnagl et al. Noradrenaline depletion protects cholinergic neurons in rat hippocampus against AF64A-induced damage
Lobato et al. Effect of subarachnoid hemorrhage on contractile responses and noradrenaline release evoked in cat cerebral arteries by histamine
KITAZAWA et al. Increase in passive calcium influx into the sarcoplasmic reticulum by “depolarization” and caffeine
Sugiura et al. Effect of heavy water (deuterium oxide) on viability of mouse sarcoma and melanoma
Guttman et al. The effect of ions upon the response of smooth muscle to cooling
Syková et al. Effects of carbon dioxide on extracellular potassium accumulation and volume in isolated frog spinal cord
Zoccarato et al. Reversibility of the ionomycin promoted synaptosomal hydrogen peroxide production
ALLEN et al. + Serosol

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: WEO LLC. (US)

B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements